-
Access to HealthcareNew drugs could offer hope for malaria patients
In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.
Access to Healthcare -
DiscoveryNovartis scientists target resistance threat in malaria
Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.
Discovery -
DiscoveryMutant protein spreads through a neural circuit in Huntington’s Disease
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
Discovery -
Patient PerspectivesLongevity with vitality: Japanese elders provide examples for healthy aging
Ogimi in Okinawa, Japan has the highest percentage of centenarians in the world, making it a curiosity for those eager to learn more about the secrets of aging.
Patient Perspectives -
DiscoveryCancer cocktails come of age
Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.
Discovery -
Combination therapies: Seeking to block cancer’s pathways to growth
Talk to any cancer researcher or doctor today and what you hear is wonder and hope.
-
DiscoveryCancer cocktails: LEE011 – a popular combination partner
Discovery -
Cancer cocktails: LJM716 – closing a common release valve
-
DiscoveryCancer cocktails: ABL001 – hitting one target twice
Discovery -
From Our LabsmHealth: A revolution in healthcare
Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.
From Our Labs -
Patient PerspectivesExperts call for new approach to patient and physician management of type 2 diabetes
A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.
Patient Perspectives -
From Our LabsWhy Novartis scouts for disruptive technology
Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.
From Our Labs